Literature DB >> 9329637

Frequencies of hprt mutant lymphocytes in smokers, non-smokers, and former smokers.

M M Ammenheuser1, D A Hastings, E B Whorton, J B Ward.   

Abstract

Previous work with the autoradiographic mutant lymphocyte assay has provided information about the time-course of development of hprt mutations and the persistence of detectable mutant cells in human subjects following therapeutic exposures to genotoxic agents. These early studies also revealed elevations in frequencies of mutant cells in pretreatment blood samples from patients who were current tobacco smokers, but no information was available on former smokers. In the present study, blood samples were obtained from 21 healthy former tobacco smokers who had quit smoking at least 1 year before sampling, 42 subjects who had never smoked, and 23 tobacco smokers. Plasma from all samples was tested for cotinine, a metabolite of nicotine. Current smokers were categorized as heavy smokers (> or = 10 cigarettes per day, cotinine > or = 90 ng/ml plasma) and light smokers (< 10/day, cotinine < 90 ng/ml). Lymphocytes from the blood samples were isolated, cryopreserved, and later thawed and assayed with the autoradiographic hprt assay. The 21 former tobacco smokers had a mean variant (mutant) frequency (Vf +/- standard error) of 1.97 (+/-0.13) per million evaluatable cells. The Vf of 42 subjects who had never smoked was 1.74 (+/-0.13) x 10(-6), not significantly different from the former smokers. The smokers had Vfs of 8.09 (+/-0.78) x 10(-6) for 18 heavy smokers and 5.22 (+/-1.02) x 10(-6) for five light smokers. The two categories of smokers had frequencies of mutant cells significantly different from each other, and each was significantly higher than non-smokers and former smokers (P < 0.05). Vfs were significantly correlated with both cotinine concentrations and the number of cigarettes smoked per day, P < 0.001. This study demonstrates the sensitivity of the autoradiographic hprt assay for detecting mutagenic effects related to chronic low-level exposures to genotoxins, and indicates that this assay is more likely to detect the effects of recent rather than past exposures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9329637

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  6 in total

1.  Variability in human sensitivity to 1,3-butadiene: influence of polymorphisms in the 5'-flanking region of the microsomal epoxide hydrolase gene (EPHX1).

Authors:  Sherif Z Abdel-Rahman; Marinel M Ammenheuser; Curtis J Omiecinski; Jeffrey K Wickliffe; Judah I Rosenblatt; Jonathan B Ward
Journal:  Toxicol Sci       Date:  2005-02-16       Impact factor: 4.849

2.  Evaluation of frequencies of HPRT mutant lymphocytes in butadiene polymer workers in a Southeast Texas facility.

Authors:  Jeffrey K Wickliffe; Marinel M Ammenheuser; P Jene Adler; Sherif Z Abdel-Rahman; Jonathan B Ward
Journal:  Environ Mol Mutagen       Date:  2009-03       Impact factor: 3.216

3.  Assessment of 1,3-butadiene exposure in polymer production workers using HPRT mutations in lymphocytes as a biomarker.

Authors:  M M Ammenheuser; W E Bechtold; S Z Abdel-Rahman; J I Rosenblatt; D A Hastings-Smith; J B Ward
Journal:  Environ Health Perspect       Date:  2001-12       Impact factor: 9.031

Review 4.  Molecular epidemiology studies on occupational and environmental exposure to mutagens and carcinogens, 1997-1999.

Authors:  R J Srám; B Binková
Journal:  Environ Health Perspect       Date:  2000-03       Impact factor: 9.031

5.  One year results of a randomized controlled clinical study evaluating the effects of non-surgical periodontal therapy of chronic periodontitis in conjunction with three or seven days systemic administration of amoxicillin/metronidazole.

Authors:  Raluca Cosgarea; Christian Heumann; Raluca Juncar; Roxana Tristiu; Liana Lascu; Giovanni E Salvi; Nicole B Arweiler; Anton Sculean
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

6.  Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT.

Authors:  Raluca Cosgarea; S Eick; S Jepsen; N B Arweiler; R Juncar; R Tristiu; G E Salvi; C Heumann; A Sculean
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.